NAIPP2 and triple-negative breast carcinoma: We identified, to our knowledge for the first time, the expression levels of all genes from the BIRC family in the neoplastic tissue of a tumor collected from patients diagnosed with triple negative breast cancer, not undergoing neoadjuvant chemotherapy.